EPEN-09. IMPACT OF MOLECULAR SUBGROUP ON OUTCOME FOR INFANTS <12 MONTHS WITH INTRACRANIAL EPENDYMOMA - GERMAN EXPERIENCE FROM HIT2000, INTERIM-2000-REGISTRY AND I-HIT-MED REGISTRY

BACKGROUND: For infant ependymoma (EP), decision for radiotherapy during first-line therapy is a dilemma. We analyzed therapy outcomes of EP patients younger than 12 months at diagnosis according to molecular subgroup. PATIENTS AND METHODS: Between 2001 and 2017, 30 patients with histological diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Obrecht, Denise, Mynarek, Martin, von Hoff, Katja, Witt, Hendrik, Pajtler, Kristian W, Juhnke, B Ole, Warmuth-Metz, Monika, Bison, Brigitte, Kortmann, Rolf-Dieter, Timmermann, Beate, Pfister, Stefan M, Sahm, Felix, Sturm, Dominik, von Deimling, Andreas, Schüller, Ulrich, Pietsch, Torsten, Benesch, Martin, Gerber, Nicolas U, Rutkowski, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Ependymoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715191/
http://dx.doi.org/10.1093/neuonc/noaa222.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715191/
http://dx.doi.org/10.1093/neuonc/noaa222.149

Ejemplares similares